Bon Natural Life (BON) Competitors $1.30 -0.03 (-2.26%) As of 08/5/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock BON vs. HSTO, TRVN, SRNE, PBLA, HEPA, BPTSY, VIRX, NCNA, VINC, and SYRSShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include Histogen (HSTO), Trevena (TRVN), Sorrento Therapeutics (SRNE), Panbela Therapeutics (PBLA), Hepion Pharmaceuticals (HEPA), Biophytis (BPTSY), Viracta Therapeutics (VIRX), NuCana (NCNA), Vincerx Pharma (VINC), and Syros Pharmaceuticals (SYRS). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. Its Competitors Histogen Trevena Sorrento Therapeutics Panbela Therapeutics Hepion Pharmaceuticals Biophytis Viracta Therapeutics NuCana Vincerx Pharma Syros Pharmaceuticals Histogen (NASDAQ:HSTO) and Bon Natural Life (NASDAQ:BON) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation. Does the media favor HSTO or BON? In the previous week, Bon Natural Life had 1 more articles in the media than Histogen. MarketBeat recorded 1 mentions for Bon Natural Life and 0 mentions for Histogen. Histogen's average media sentiment score of 0.00 beat Bon Natural Life's score of -1.00 indicating that Histogen is being referred to more favorably in the media. Company Overall Sentiment Histogen Neutral Bon Natural Life Negative Which has more volatility & risk, HSTO or BON? Histogen has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Bon Natural Life has a beta of -0.47, suggesting that its stock price is 147% less volatile than the S&P 500. Which has stronger valuation and earnings, HSTO or BON? Bon Natural Life has higher revenue and earnings than Histogen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogen$19K0.07-$10.62M-$2.810.00Bon Natural Life$23.84M0.01$400KN/AN/A Do institutionals and insiders believe in HSTO or BON? 0.6% of Bon Natural Life shares are owned by institutional investors. 3.3% of Histogen shares are owned by company insiders. Comparatively, 26.5% of Bon Natural Life shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is HSTO or BON more profitable? Company Net Margins Return on Equity Return on Assets HistogenN/A N/A N/A Bon Natural Life N/A N/A N/A SummaryBon Natural Life beats Histogen on 5 of the 8 factors compared between the two stocks. Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeCONSM PD IndustryDiscretionary SectorNASDAQ ExchangeMarket Cap$220K$2.37B$8.12B$9.53BDividend YieldN/A4.52%3.22%4.14%P/E RatioN/A19.5619.1223.88Price / Sales0.012.114.4998.82Price / Cash0.1317.0316.4358.35Price / Book0.001.624.465.60Net Income$400K$103.54M$218.40M$265.26M7 Day Performance-1.52%-3.30%-0.50%-0.14%1 Month Performance-13.33%-6.66%38.54%6.08%1 Year PerformanceN/A-13.81%24.73%24.22% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural Life0.3342 of 5 stars$1.30-2.3%N/AN/A$220K$23.84M0.00100Negative NewsShort Interest ↑HSTOHistogenN/A$0.00flatN/AN/A$918K$19K0.0020TRVNTrevena1.5631 of 5 stars$0.91flat$5.00+449.5%-94.7%$873K$443K-0.0240SRNESorrento Therapeutics0.8858 of 5 stars$0.00+7.7%N/A-77.0%$772K$60.32M0.00800Gap DownPBLAPanbela Therapeutics0.1587 of 5 stars$0.16flatN/A-49.1%$767KN/A0.006HEPAHepion Pharmaceuticals0.4848 of 5 stars$0.06-5.0%N/A-99.9%$686KN/A-0.0120Upcoming EarningsGap UpBPTSYBiophytisN/A$1.81flatN/AN/A$634KN/A0.0030VIRXViracta Therapeutics1.7249 of 5 stars$0.01flat$1.75+17,793.7%N/A$389KN/A-0.0120Upcoming EarningsShort Interest ↑NCNANuCana2.5902 of 5 stars$0.06+10.4%$25.00+41,846.3%-98.8%$330KN/A-0.0130Negative NewsUpcoming EarningsGap UpHigh Trading VolumeVINCVincerx Pharma2.6894 of 5 stars$0.05-21.8%$40.00+86,856.5%-99.7%$308KN/A0.0060Upcoming EarningsSYRSSyros Pharmaceuticals4.0426 of 5 stars$0.01-49.5%$3.33+32,903.3%-100.0%$271K$386K0.00120Gap Down Related Companies and Tools Related Companies Histogen Competitors Trevena Competitors Sorrento Therapeutics Competitors Panbela Therapeutics Competitors Hepion Pharmaceuticals Competitors Biophytis Competitors Viracta Therapeutics Competitors NuCana Competitors Vincerx Pharma Competitors Syros Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BON) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
